Reaction

Dilatation Atrial reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,165 reports · 26 co-occurring drugs

As of the last recalculation, Dilatation Atrial appears in 1,165 FAERS reports alongside 26 co-occurring drug terms. The strongest observed disproportionality signal is DIGOXIN (PRR 32.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Digoxin11832.632.6
Enalapril Maleate3122.923.0
Metolazone1422.522.5
Quinine918.918.9
Cimetidine1018.718.7
Losartan Potassium And Hydrochlorothiazide1218.618.7
Diltiazem Hydrochloride3518.618.6
Amlodipine Besylate And Benazepril Hydrochloride917.517.6
Glyburide2015.015.0
Nitroglycerin4114.114.1
Epoetin Alfa913.713.7
Amiodarone Hydrochloride812.812.8
Dronedarone712.312.3
Doxazosin1912.312.3
Tafamidis812.212.2
Isosorbide Dinitrate1312.012.0
Ezetimibe And Simvastatin1011.811.9
Warfarin Sodium2911.411.4
Lovastatin1510.610.6
Estrogens, Conjugated3310.210.2
Conjugated Estrogens3210.110.1
Glipizide339.99.9
Rotigotine67.47.4
Conjugated Estrogens And Medroxyprogesterone Acetate86.16.1
Hydrocodone Bitartrate104.14.1
Orlistat53.53.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.